Sharing History Through Active Reminiscence and Photo-imagery - With MCI
SHARP-MCI
1 other identifier
interventional
23
1 country
1
Brief Summary
The SHARP-MCI study tests impact of walking and social reminiscence on cognitive function, blood pressure, and weight among healthy Black Americans and those experiencing mild cognitive impairment (MCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started May 2017
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 7, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedJune 18, 2023
May 1, 2023
11 months
June 7, 2023
June 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Cognitive function
Pre/post Montreal Cognitive Assessment
24 weeks
Secondary Outcomes (2)
Blood pressure
24 weeks
Weight
24 weeks
Study Arms (1)
Intervention Group
EXPERIMENTALAll participants assigned to the experimental group (walking)
Interventions
Participants engage in neighborhood walks and conversational reminisce three times per week over 24 weeks
Eligibility Criteria
You may qualify if:
- Self-identified African American
- \> 55 years old
- Reside or resided for \>10 years in Portland's historically Black neighborhoods (to be familiar with Memory Markers about this area)
- Able to ambulate independently. Participants (n=7) with MCI will meet criteria consistent with those defined by Jak et al. 2009 and with criteria outlined by the NIA-Alzheimer's Association workgroup (2011)
- Participants without cognitive impairment (n=14) will have an MMSE score \> 24 (and not meet MCI criteria).
- Participants' cognitive function should allow them to get to/ from walk locations independently or with minimal assistance
You may not qualify if:
- Serious or unstable medical condition (such as, but not limited to, cardiovascular disease, pulmonary disease, or severe arthritis) where participation in the trial would, in the opinion of the investigator, pose a significant health risk to the subject.
- Diagnosis of Alzheimer's disease, vascular dementia, Parkinson's disease, or other dementing illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
Related Publications (2)
Carder, P., Croff, R., Tuttle, A., Towns, J. (2022) Walking and Talking: Recommendations for Doing Mobile Interviews with Older Adults. Journal of Aging and Environment, DOI: 10.1080/26892618.2022.2030844
BACKGROUNDCroff R, Aron S, Wachana A, Fuller P, Mattek N, Towns J, Kaye J. Walking and Social Reminiscence in Gentrifying Neighborhoods: Feasibility and Impact on Cognitive, Physical, and Mental Health Among Older Black Adults in the SHARP Study. Gerontologist. 2024 Sep 1;64(9):gnae019. doi: 10.1093/geront/gnae019.
PMID: 38412543DERIVED
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2023
First Posted
June 18, 2023
Study Start
May 24, 2017
Primary Completion
April 30, 2018
Study Completion
August 30, 2020
Last Updated
June 18, 2023
Record last verified: 2023-05